Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1272, 2001-01, pp. : 19-19
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
No long-term QOL benefit for CRT
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 637, 2011-01 ,pp. :
Enfuvirtide-based treatment provides long-term benefit
Inpharma, Vol. 1, Iss. 1452, 2004-01 ,pp. :
Interferons in MS: long-term clinical benefit uncertain
Inpharma, Vol. 1, Iss. 1375, 2003-01 ,pp. :
Long-Term Complications of Chemotherapy for Germ Cell Tumours
Drugs, Vol. 63, Iss. 15, 2003-01 ,pp. :
Tamoxifen: long-term benefit in ER-positive breast cancer
Inpharma, Vol. 1, Iss. 1584, 2007-01 ,pp. :